LSL Pharma Group Inc.
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
52.7M
P/E Ratio
21.75
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.
Healthcare
Drug Manufacturers - Specialty & Generic
TSXV
Key Financial Metrics
17.7M
Revenue
3.3M
Net Income
C$0.03
EPS (Diluted)
-5.9M
Free Cash Flow
Profitability
Gross Margin
30.1%
Operating Margin
2.3%
Net Profit Margin
18.7%
EBITDA
6.6M
Returns & Efficiency
Return on Assets (ROA)
6.2%
Return on Equity (ROE)
13.3%
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
53.5M
Total Debt
21.6M
Debt to Equity
0.87x
Current Ratio
1.59
Company Info
| Industry | Drug Manufacturers - Specialty & Generic |
| HQ | Boucherville, Canada |
| Employees | 186 |
| Fiscal Year End | 1735603200 |
| Currency | CAD |
| Website | www.groupelslpharma.com |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
337,500
Shares Sold
0
Total Transactions
10
SEDAR+ Filings
View All Filings3
Annual Reports
12
Quarterly Reports
16
MD&A
42
News Releases
20
Material Changes
45
Certifications
21
Other
●
25 Nov 2021
●
2025-10-17
●
2021-11-25
Interactive Charts
Company Profile
General Information
| Company Name | LSL Pharma Group Inc. |
| Ticker | LSL.V |
| Exchange | TSXV |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Headquarters | Boucherville, Canada |
| Employees | 186 |
| Fiscal Year End | 1735603200 |
| Currency | CAD |
| Website | www.groupelslpharma.com |
Financial Summary
| Market Cap | 52.7M |
| Revenue | 17.7M |
| Net Income | 3.3M |
| P/E Ratio | 21.75 |
| EPS (Diluted) | C$0.03 |
| Net Margin | 18.7% |
| ROE | 13.3% |
| Dividend Yield | N/A |
Business Description
LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. The company offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, and natural health products in liquid and semi-solid form for pharmacy banners and hospitals. The company is headquartered in Boucherville, Canada.